Table 4.
No. of participants |
Age-adjusted |
Multivariable-adjusted |
|||||
---|---|---|---|---|---|---|---|
β coefa | 95% CI | P for trendc | β coefb | 95% CI | P for trendc | ||
By cotinine categories | |||||||
Non-Hispanic Whites |
3328 | 0.007 | 0.07 | ||||
0–0.049 ng/ml | 1529 | Ref | |||||
0.05–2.99 ng/ml | 898 | −10.55 | −105.86, 84.77 | 6.77 | −85.30, 99.14 | ||
≥3 ng/ml | 901 | −92.40d | −150.99, −33.81 | −77.92d | −143.05, −11.70 | ||
Non-Hispanic Blacks |
1061 | 0.749 | 0.59 | ||||
0–0.049 ng/ml | 242 | Ref | |||||
0.05–2.99 ng/ml | 430 | −16.44 | −141.43, 108.53 | −9.12 | −134.91, 116.66 | ||
≥3 ng/ml | 389 | −22.50 | −156.80, 111.8 | −43.06 | −200.08, 113.96 | ||
Mexican Americans | 1475 | 0.08 | 0.15 | ||||
0–0.049 ng/ml | 782 | Ref | |||||
0.05–2.99 ng/ml | 414 | 57.71 | −57.9, 173.32 | 63.53 | −50.19, 177.26 | ||
≥3 ng/ml | 279 | 90.78 | −2.50, 182.06 | 75.28 | −20.38, 170.96 | ||
By cotinine concentration | |||||||
Non-Hispanic Whites | 3328 | ||||||
0–9.99 ng/ml | 2474 | Ref | Ref | ||||
≥10 ng/ml | 854 | −87.29 | −133.27, −41.31 | −74.25 | −120.84, −27.66 | ||
Non-Hispanic Blacks | 1061 | ||||||
0–9.99 ng/ml | 702 | Ref | Ref | ||||
≥10 ng/ml | 359 | 21.37 | −92.46, 135.21 | 20.10 | −80.25, 130.45 | ||
Mexican Americans | 1475 | ||||||
0–9.99 ng/ml | 1225 | Ref | Ref | ||||
≥10 ng/ml | 250 | 75.45 | −13.58, 172.49 | 85.08 | −10.97, 177.15 | ||
By cotinine levels | |||||||
Non-Hispanic Whites |
3328 | −0.30d | −0.5, −0.11 | −0.25d | −0.43, −0.07 | ||
Non-Hispanic Blacks |
1061 | −0.10 | −0.37, 0.16 | −0.23 | −0.48, 0.03 | ||
Mexican Americans | 1475 | 0.67 | 0.01, 1.33 | 0.61 | −0.03, 1.25 |
Abbreviation: CI, confidence interval.
Values are adjusted β coefficients. Analyses were performed with adjustment for sample weights and design effects.
Adjusted for age.
Adjusted for sex, educational level, marital status, body mass index, smoking status, physical activity, alcohol consumption, total calorie intake, chronic disease conditions including diabetes, high blood pressure, congestive heart failure, asthma, cancer or malignancy and CRP levels.
P for trend across cotinine categories.
p < 0.05.